Terminated PHASE2 INTERVENTIONAL 3-arm NCT04110873

A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis

A Phase II, Three-arms, Double-blind, Dosing-ranging, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis

Sponsor: Chung Shan Medical University

Conditions Atopic Dermatitis

Interventions Antroquinonol Capsule 100mg Antroquinonol Capsule 50mg Placebo oral capsule

Updated 4 times since 2019 Last updated: Sep 30, 2019 Started: Jul 27, 2018 Primary completion: Jun 25, 2019 Completion: Jun 25, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

It was hard to find suitable subject due to strict enrollment criteria.

Other Atopic Dermatitis trials with similar outcome

Browse all Atopic Dermatitis trials

This PHASE2 trial investigates Atopic Dermatitis and is currently terminated or withdrawn. Chung Shan Medical University leads this study, which shows 4 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Nov 2019 — Jan 2021 [monthly]

Terminated PHASE2

First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chung Shan Medical University
Golden Biotechnology Corporation

Data source: Chung Shan Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taichung, Taiwan